Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 6157491, 8 pages
https://doi.org/10.1155/2017/6157491
Research Article

The Antimicrobial Peptide Human Beta-Defensin-3 Is Induced by Platelet-Released Growth Factors in Primary Keratinocytes

1Department of Heart and Vascular Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller Straße 3, Haus 26, 24105 Kiel, Germany
2Department of Dermatology, University Hospital of Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 7, 24105 Kiel, Germany
3Institute of Anatomy and Cell Biology, RWTH University of Aachen, Wendlingweg 2, 52072 Aachen, Germany
4Department of Traumatology, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller Straße 3, Haus 18, 24105 Kiel, Germany
5Department of Orthopaedics, Aachen University Hospital, Pauwelsstraße 30, 52074 Aachen, Germany

Correspondence should be addressed to Andreas Bayer; ed.bew@leik-reyabsaerdna

Received 19 January 2017; Accepted 6 July 2017; Published 25 July 2017

Academic Editor: Vinod K. Mishra

Copyright © 2017 Andreas Bayer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. Eppley, J. E. Woodell, and J. Higgins, “Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing,” Plastic and Reconstructive Surgery, vol. 114, no. 6, pp. 1502–1508, 2004. View at Google Scholar
  2. G. Weibric, R. S. R. Buch, W. K. G. Kleis, G. Hafner, W. E. Hitzler, and W. Wagner, “Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation,” Growth Factors (Chur, Switzerland), vol. 20, no. 2, pp. 93–97, 2002. View at Google Scholar
  3. M. Yazawa, H. Ogata, T. Nakajima, T. Mori, N. Watanabe, and M. Handa, “Basic studies on the clinical applications of platelet-rich plasma,” Cell Transplantation, vol. 12, no. 5, pp. 509–518, 2003. View at Google Scholar
  4. E. Anitua, I. Andia, B. Ardanza, P. Nurden, and A. T. Nurden, “Autologous platelets as a source of proteins for healing and tissue regeneration,” Thrombosis and Haemostasis, vol. 91, no. 1, pp. 4–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. van den Dolder, R. Mooren, A. P. G. Vloon, P. J. W. Stoelinga, and J. A. Jansen, “Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells,” Tissue Engineering, vol. 12, no. 11, pp. 3067–3073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Yamaguchi, H. Terashima, S. Yoneyama, S. Tadano, and N. Ohkohchi, “Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor,” The Journal of Surgical Research, vol. 173, no. 2, pp. 258–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Graziani, S. Ivanovski, S. Cei, F. Ducci, M. Tonetti, and M. Gabriele, “The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts,” Clinical Oral Implants Research, vol. 17, no. 2, pp. 212–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Rughetti, I. Giusti, S. D’Ascenzo et al., “Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells,” Blood Transfusion, vol. 6, no. 1, pp. 12–17, 2008. View at Google Scholar
  9. M. Kawasumi, H. Kitoh, K. A. Siwicka, and N. Ishiguro, “The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone,” The Journal of Bone and Joint Surgery, vol. 90, no. 7, pp. 966–972, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Arpornmaeklong, M. Kochel, R. Depprich, N. R. Kübler, and K. K. Würzler, “Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study,” International Journal of Oral and Maxillofacial Surgery, vol. 33, no. 1, pp. 60–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kakudo, N. Morimoto, S. Kushida, T. Ogawa, and K. Kusumoto, “Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo,” Medical Molecular Morphology, vol. 47, no. 2, pp. 83–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kakudo, S. Kushida, T. Minakata, K. Suzuki, and K. Kusumoto, “Platelet-rich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site,” Medical Molecular Morphology, vol. 44, no. 4, pp. 233–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Steenvoorde, L. P. van Doorn, C. Naves, and J. Oskam, “Use of autologous platelet-rich fibrin on hard-to-heal wounds,” Journal of Wound Care, vol. 17, no. 2, pp. 60–63, 2008. View at Publisher · View at Google Scholar
  14. S. Scharf, J. Zahlten, K. Szymanski, S. Hippenstiel, N. Suttorp, and P. D. N’Guessan, “Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium,” Experimental Lung Research, vol. 38, no. 2, pp. 100–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kawauchi, A. Yagihashi, N. Tsuji et al., “Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues,” World Journal of Gastroenterology, vol. 12, no. 36, pp. 5793–5797, 2006. View at Publisher · View at Google Scholar
  16. K. Kiehne, A. Fincke, G. Brunke, T. Lange, U. R. Fölsch, and K. H. Herzig, “Antimicrobial peptides in chronic anal fistula epithelium,” Scandinavian Journal of Gastroenterology, vol. 42, no. 9, pp. 1063–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Bayer, J. Lammel, F. Rademacher et al., “Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes,” Experimental Dermatology, vol. 25, no. 6, pp. 460–465, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Harder, J. Bartels, E. Christophers, and J. M. Schroder, “Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic,” The Journal of Biological Chemistry, vol. 276, no. 8, pp. 5707–5713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ishimoto, H. Mukae, Y. Date et al., “Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia,” The European Respiratory Journal, vol. 27, no. 2, pp. 253–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Zanger, D. Nurjadi, B. Vath, and P. G. Kremsner, “Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo,” Infection and Immunity, vol. 79, no. 7, pp. 2658–2662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Wittersheim, J. Cordes, U. Meyer-Hoffert, J. Harder, J. Hedderich, and R. Gläser, “Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta-defensin-2 and -3 in healthy human skin,” Experimental Dermatology, vol. 22, no. 5, pp. 364–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. O. E. Sørensen, J. B. Cowland, K. Theilgaard-Mönch, L. Liu, T. Ganz, and N. Borregaard, “Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors,” Journal of Immunology, vol. 170, no. 11, pp. 5583–5589, 2003. View at Google Scholar
  23. T. Hirsch, M. Spielmann, B. Zuhaili et al., “Human beta-defensin-3 promotes wound healing in infected diabetic wounds,” The Journal of Gene Medicine, vol. 11, no. 3, pp. 220–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Roth, M. Simanski, F. Rademacher, L. Schröder, and J. Harder, “The pattern recognition receptor NOD2 mediates Staphylococcus aureus-induced IL-17C expression in keratinocytes,” The Journal of Investigative Dermatology, vol. 134, no. 2, pp. 374–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. N. Parker, K. J. Finlayson, P. Shuter, and H. E. Edwards, “Risk factors for delayed healing in venous leg ulcers: a review of the literature,” International Journal of Clinical Practice, vol. 69, no. 9, pp. 1029-1030, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Alsousou, A. Ali, K. Willett, and P. Harrison, “The role of platelet-rich plasma in tissue regeneration,” Platelets, vol. 24, no. 3, pp. 173–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Alsousou, M. Thompson, P. Hulley, A. Noble, and K. Willett, “The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature,” The Journal of Bone and Joint Surgery. British Volume, vol. 91, no. 8, pp. 987–996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. H. Redler, S. A. Thompson, S. H. Hsu, C. S. Ahmad, and W. N. Levine, “Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use,” The Physician and Sportsmedicine, vol. 39, no. 1, pp. 42–51, 2011. View at Publisher · View at Google Scholar
  29. T. E. Foster, B. L. Puskas, B. R. Mandelbaum, M. B. Gerhardt, and S. A. Rodeo, “Platelet-rich plasma: from basic science to clinical applications,” The American Journal of Sports Medicine, vol. 37, no. 11, pp. 2259–2272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Baeyens, R. Glineur, and L. Evrard, “The use of platelet concentrates: platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in bone reconstruction prior to dental implant surgery,” Revue Médicale de Bruxelles, vol. 31, no. 6, pp. 521–527, 2010. View at Google Scholar
  31. E. Anitua, J. J. Aguirre, J. Algorta et al., “Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers,” Journal of Biomedical Materials Research. Part B, Applied Biomaterials, vol. 84, no. 2, pp. 415–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Orcajo, F. Muruzabal, M. C. Isasmendi et al., “The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes,” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. e65–e67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Molina-Miñano, P. López-Jornet, F. Camacho-Alonso, and V. Vicente-Ortega, “The use of plasma rich in growth factors on wound healing in the skin: experimental study in rabbits,” International Wound Journal, vol. 6, no. 2, pp. 145–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. L. J. Xian, S. R. Chowdhury, A. Bin Saim, and R. B. Idrus, “Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing,” Cytotherapy, vol. 17, no. 3, pp. 293–300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. C. Barsotti, M. Chiara Barsotti, P. Losi et al., “Effect of platelet lysate on human cells involved in different phases of wound healing,” PLoS One, vol. 8, no. 12, article e84753, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Dunsche, Y. Açil, H. Dommisch, R. Siebert, J. M. Schröder, and S. Jepsen, “The novel human beta-defensin-3 is widely expressed in oral tissues,” European Journal of Oral Sciences, vol. 110, no. 2, pp. 121–124, 2002. View at Publisher · View at Google Scholar
  37. N. A. Nakra, R. P. Madan, N. Buckley et al., “Loss of innate host defense following unprotected vaginal sex,” The Journal of Infectious Diseases, vol. 213, no. 5, pp. 840–847, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. K. O. Kisich, M. D. Howell, M. Boguniewicz, H. R. Heizer, N. U. Watson, and D. Y. M. Leung, “The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3,” The Journal of Investigative Dermatology, vol. 127, no. 10, pp. 2368–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. H. Firat, M. Simanski, F. Rademacher, L. Schröder, J. Brasch, and J. Harder, “Infection of keratinocytes with Trichophytum rubrum induces epidermal growth factor-dependent RNase 7 and human beta-defensin-3 expression,” PLoS One, vol. 9, no. 4, article e93941, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Maisetta, G. Batoni, S. Esin et al., “In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, pp. 806–809, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. R. García, F. Jaumann, S. Schulz et al., “Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction,” Cell and Tissue Research, vol. 306, no. 2, pp. 257–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Batoni, G. Maisetta, S. Esin, and M. Campa, “Human beta-defensin-3: a promising antimicrobial peptide,” Mini Reviews in Medicinal Chemistry, vol. 6, no. 10, pp. 1063–1073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Niyonsaba, H. Ushio, N. Nakano et al., “Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines,” The Journal of Investigative Dermatology, vol. 127, no. 3, pp. 594–604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. S. Muhammad, S. F. Zaidi, Y. Zhou, H. Sakurai, and T. Sugiyama, “Novel epidermal growth factor receptor pathway mediates release of human β-defensin 3 from helicobacter pylori-infected gastric epithelial cells,” Pathogens and Disease, vol. 74, no. 3, 2016. View at Publisher · View at Google Scholar
  45. O. E. Sørensen, D. R. Thapa, A. Rosenthal, L. Liu, A. A. Roberts, and T. Ganz, “Differential regulation of beta-defensin expression in human skin by microbial stimuli,” Journal of Immunology, vol. 174, no. 8, pp. 4870–4879, 2005. View at Google Scholar
  46. O. E. Sorensen, D. R. Thapa, K. M. Roupé et al., “Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1878–1885, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Zhu, H. Tan, T. Cheng et al., “Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation,” Journal of Surgical Research, vol. 183, no. 1, pp. 204–213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Q. Huang, H.-J. Yu, G.-D. Liu et al., “Comparison of the effects of human β-defensin 3, vancomycin, and clindamycin on Staphylococcus aureus biofilm formation,” Orthopedics, vol. 35, no. 1, pp. e53–e60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Mihara, M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina, “IL-6/IL-6 receptor system and its role in physiological and pathological conditions,” Clinical Science (London), vol. 122, no. 4, pp. 143–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. C. E. Rolle, J. Chen, I. Pastar et al., “Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A,” Immunologic Research, vol. 57, no. 1–3, pp. 258–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Liu, F. Yang, Z. Li, C. Yi, and X. Bai, “A prospective pilot study to evaluate wound outcomes and levels of serum C-reactive protein and interleukin-6 in the wound fluid of patients with trauma-related chronic wounds,” Ostomy/Wound Management, vol. 60, no. 6, pp. 30–37, 2014. View at Google Scholar
  52. K. A. Kuhn, N. A. Manieri, T. C. Liu, and T. S. Stappenbeck, “IL-6 stimulates intestinal epithelial proliferation and repair after injury,” PloS One, vol. 9, no. 12, article e114195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. J. H. Choi, J. H. Jun, J. H. Kim, H. J. Sung, and J. H. Lee, “Synergistic effect of interleukin-6 and hyaluronic acid on cell migration and ERK activation in human keratinocytes,” Journal of Korean Medical Science, vol. 29, Supplement 3, pp. S210–S216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Arranz-Valsero, L. Soriano-Romaní, L. García-Posadas, A. López-García, and Y. Diebold, “IL-6 as a corneal wound healing mediator in an in vitro scratch assay,” Experimental eye Research, vol. 125, pp. 183–192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. O. E. Sørensen, J. B. Cowland, K. Theilgaard-Mönch, L. Liu, T. Ganz, and N. Borregaard, “Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors,” Journal of Immunology (Baltimore, Md. : 1950), vol. 170, no. 11, pp. 5583–5589, 2003. View at Google Scholar